CanSino Biologics Inc. (OTCMKTS:CASBF) Short Interest Update

CanSino Biologics Inc. (OTCMKTS:CASBF) saw a significant decline in short interest in January. As of January 31st, there was short interest totalling 13,400 shares, a decline of 8.2% from the January 15th total of 14,600 shares. Based on an average daily trading volume, of 100 shares, the short-interest ratio is currently 134.0 days.

CanSino Biologics Price Performance

CASBF stock opened at C$3.37 on Tuesday. CanSino Biologics has a 52 week low of C$1.86 and a 52 week high of C$4.35. The firm has a 50-day simple moving average of C$3.69 and a 200-day simple moving average of C$3.27.

CanSino Biologics Company Profile

CanSino Biologics Inc develops, manufactures, and commercializes vaccines in the People's Republic of China. The company develops Convidecia and the Ad5-nCoV for Inhalation vaccines to recombinant novel coronavirus disease; Ad5-EBOV, an Ebola virus vaccine; and MCV2 and MCV4 vaccines for the prevention of N.